Proteasome inhibitors protect the steatotic and non-steatotic liver graft against cold ischemia reperfusion injury |
| |
Authors: | Mohamed Amine Zaouali,Fawzia Bardag-Gorce,Teresa Carbonell,Joan Oliva,Eirini Pantazi,Mohamed Bejaoui,Hassen Ben Abdennebi,Antoni Rimola,Joan Roselló -Catafau |
| |
Affiliation: | 1. Experimental Hepatic Ischemia-Reperfusion Unit, Institut d´Investigacions Biomèdiques de Barcelona-Consejo Superior de Investigaciones Científicas, Barcelona, Spain;2. Harbor-UCLA Medical Center, Torrance, CA, USA;3. Department de Fisiologia, Facultat de Biología, Universitat de Barcelona, Barcelona, Spain;4. Laboratory of Human Physiology, Faculty of Pharmacy, University of Monastir, Monastir, Tunisia;5. Ciberehd, Hospital Clínic, Barcelona, Spain |
| |
Abstract: | BackgroundThe dramatic shortage of organs leads to consider the steatotic livers for transplantation although their poor tolerance against ischemia reperfusion injury (IRI). Ubiquitin proteasome system (UPS) inhibition during hypothermia prolongs myocardial graft preservation. The role of UPS in the liver IRI is not fully understood. Bortezomib (BRZ) treatment at non-toxic doses of rats fed alcohol chronically has shown protective effects by increasing liver antioxidant enzymes. We evaluated and compared both proteasome inhibitors BRZ and MG132 in addition to University of Wisconsin preservation solution (UW) at low and non-toxic dose for fatty liver graft protection against cold IRI.ExperimentalSteatotic and non-steatotic livers have been stored in UW enriched with BRZ (100 nM) or MG132 (25 μM), for 24 h at 4 °C and then subjected to 2-h normothermic reperfusion (37 °C). Liver injury (AST/ALT), hepatic function (bile output; vascular resistance), mitochondrial damage (GLDH), oxidative stress (MDA), nitric oxide (NO) (e-NOS activity; nitrates/nitrites), proteasome chymotrypsin-like activity (ChT), and UPS (19S and 20S5 beta) protein levels have been measured.ResultsChT was inhibited when BRZ and MG132 were added to UW. Both inhibitors prevented liver injury (AST/ALT), when compared to UW alone. BRZ increased bile production more efficiently than MG132. Only BRZ decreased vascular resistance in fatty livers, which correlated with an increase in NO generation (through e-NOS activation) and AMPK phosphorylation. GLDH and MDA were also prevented by BRZ. In addition, BRZ inhibited adiponectin, IL-1, and TNF alpha, only in steatotic livers.ConclusionMG132 and BRZ, administrated at low and non toxic doses, are very efficient to protect fatty liver grafts against cold IRI. The benefits of BRZ are more effective than those of MG132. This evidenced for the first time the potential use of UPS inhibitors for the preservation of marginal liver grafts and for future applications in the prevention of IRI. |
| |
Keywords: | Ischemia reperfusion injury Steatotic liver UW preservation solution Bortezomib MG132 UPS inhibitor |
本文献已被 ScienceDirect 等数据库收录! |
|